MOLOGEN Lifescience AG (Frankfurt:U1DA.F)
| Market Cap | 220.50K+16.7% |
| Revenue (ttm) | n/a |
| Net Income | n/a+96.8% |
| EPS | n/a+98.6% |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2 |
| Open | 2.80 |
| Previous Close | 2.80 |
| Day's Range | 2.80 - 2.80 |
| 52-Week Range | 1.10 - 4.84 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About U1DA.F
MOLOGEN Lifescience AG operates as an investment company in Germany. It focuses on investments in seed and series A and B company phases, as well as in investment phases in the fields of fintech, blockchain, and related technologies. The company was formerly known as Finchain Capital Partners AG and changed its name to MOLOGEN Lifescience AG in April 2026. MOLOGEN Lifescience AG was founded in 2015 and is headquartered in Düsseldorf, Germany.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$U1DA.F stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in U1DA.F holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by U1DA.F's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
U1DA.F Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New U1DA.F patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to U1DA.F from public contracts
Source: USAspending.gov
U1DA.F Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from U1DA.F’s recent data — informational, not investment advice